[Drug therapy of bronchosecretolytic disorders].
D000111:Acetylcysteine / Q000627:therapeutic use; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001964:Bromhexine / Q000627:therapeutic use; D001980:Bronchi / Q000378:metabolism; D001982:Bronchial Diseases / Q000188:drug therapy*; D002923:Cilia; D003902:Detergents / Q000627:therapeutic use; D005100:Expectorants / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009092:Mucous Membrane / Q000187:drug effects; D009093:Mucus / Q000187:drug effects / Q000378:metabolism; D010277:Parasympathomimetics / Q000627:therapeutic use; D010447:Peptide Hydrolases / Q000494:pharmacology; D012018:Reflex; D014867:Water / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D003902:Detergents; D005100:Expectorants; D010277:Parasympathomimetics; D014867:Water; D010447:Peptide Hydrolases; D001964:Bromhexine; D000111:Acetylcysteine
Medikamentöse Therapie bronchosekretorischer Störungen